Market revenue in 2023 | USD 1,042.1 million |
Market revenue in 2030 | USD 2,074.6 million |
Growth rate | 10.3% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceutical industry |
Fastest growing segment | Diagnostics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
Pharmaceutical industry was the largest segment with a revenue share of 43.21% in 2023. Horizon Databook has segmented the Italy in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
Various factors such as higher cost of animal testing, easy availability of alternatives, and advancements in technologies such as cell culture technology, molecular imaging, and high throughput technology are anticipated to drive Italy’s in-vitro toxicology testing market.
For instance, the Italian Association of In Vitro Toxicology (CELLTOX) is an organization founded in 1991 to bring together researchers from private and public institutions to conduct research activities in in vitro toxicology field to develop alternative ways for animal testing methods.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account